With the end of the transition period on 31 December 2020, the EU legislation governing the EU trademark and design system ceased to apply to the UK. While Brexit trade deal talks were in full swing, the SPB Team worked through all administrative details to comply with the new Brexit requirements, which took effect on … Continue Reading
With the Brexit transition period ending on December 31st, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is issuing guidance for the UK Life Science industry – including guidance on clinical trials, market authorizations, and manufacture and supply, among other areas. The guidance will apply from the start of 2021. Squire Patton Boggs’ Triage … Continue Reading
Our Intellectual Property & Technology Practice partner Deborah Lodge (Washington) will be speaking in a Clear Law Institute webinar on the European Trademark system and Brexit’s impact on trademark rights – Deciphering and Maximizing Key Benefits of the European Trademark System and the Fallout from Brexit scheduled for June 21, 2017 at 1:00 to 2:15 pm … Continue Reading
With the UK’s referendum on membership of the EU now just a month away, the focus is on what the likely impact of a Brexit would be. We have prepared an article summarising the impact a Brexit would have on the protection and enforcement of intellectual property rights in the UK. This will be relevant … Continue Reading
